Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome.
Luoyan AiYimeng RenYiting LiHaoyan ChenYun QianShiyuan LuAntao XuLinlin RenShuliang ZhaoZhaofei ChenYing-Xuan ChenJie XuJing-Yuan FangPublished in: International journal of cancer (2019)
The molecular mechanisms that control the development of colorectal cancer (CRC) remain poorly defined. Here we show Synbindin promoted CRC oncogenesis by activating Wnt signaling and altering gut microbiome. Synbindin upregulation in human CRCs was associated with poor patient prognosis. Intestine-specific disruption of Synbindin balanced the disturbed gut microbiota and protected mice against tumor formation in the colitis-associated cancer (CAC) model. The protective role was compromised after gut microbiota depletion. In host, increased goblet cells and mucin2 expression, together with increased intestinal epithelial cells (IECs) apoptosis and decreased epithelial proliferation were observed. Further transcriptomic sequencing identified Wnt signaling a major regulatory node downstream of Synbindin. Combined molecular and cellular characterizations revealed that Synbindin confers Disheveled-3 (DVL3)-based signalosome assembly and acts as a modular scaffold for DVL3 and Axin2 complex, orchestrating the intensity of Wnt signaling. These findings identify a critical role of Synbindin in gut microbiome composition and Wnt signaling activation in colorectal carcinogenesis, and highlight Synbindin as an adaptor protein with multifaceted roles.
Keyphrases
- signaling pathway
- poor prognosis
- single cell
- cell cycle arrest
- cell proliferation
- induced apoptosis
- endothelial cells
- oxidative stress
- stem cells
- cell death
- lymph node
- transcription factor
- case report
- type diabetes
- young adults
- binding protein
- metabolic syndrome
- rna seq
- skeletal muscle
- adipose tissue
- insulin resistance
- squamous cell
- ulcerative colitis